Follow your Heart

Coala Heart Monitor

Analyze your heart - anywhere, anytime.

Introducing the Coala Heart Monitor, a unique medical system that records and analyzes your heart sounds and ECG in just a minute.

Smart, cloud-based algorithms analyze instantly and detect for Atrial Fibrillation (based on P-wave detection and RR variability), 8 other arrhythmia's and the ability to detect murmurs.

Results are presented in the Coala App and the Coala Care cloud based system within seconds. The Coala is ideal for smart remote assessments and telemedicine.

No more off-line sticky electrodes, patches or wires. No limits in time or place. You're simply in control and engaged with smart medical technology for your heart.

To read news about Coala, click here.

Simply medical perfection

Coala Life is an award-winning developer of user-centered medical solutions enabling daily monitoring and analysis of the heart. Solutions are available in both consumer and professional configurations to help predict and aid the early detection of heart diseases. Ground-breaking digital services open for everyone, based on more than 10 years of Swedish R&D. Coala Life's solutions are all CE Class IIa and FDA 510(k) cleared for home and professional use.

Capture your ECG and heart sound simultaneously

You analyze your heart by simply holding the Coala for 30 seconds towards your chest, followed by 30 seconds of thumb-ECG. The patent pending double ECG recording maximizes quality, precision and accuracy - with less artifacts and need to redo the recording.

Results presented within seconds in the Coala App

The analysis is performed securely and HIPAA-compliant in the cloud based on smart, validated algorithms. The Coala analyzes for 9 different cardiac pathologies, including AF, PVC, PAC, AV block II etc. The results of the analysis are presented within seconds to the user in the Coala App (not all categories available on the US market).

Coalas state-of-the-art algorithms analyze based on P-wave detection and RR variability, unlike conventional AF screening solutions that typically only detect for RR variability. For more info see here.

So much more than a single lead AF detector, it's a complete cloud based cardiac service

The results are accessed and available instantly in the Coala Care Portal. A smart platform where users grant clinicians right to access and assess their data. The Coala Care Portal enables further remote analysis, auscultation, ability to create PDF's, download the raw data and communicate with users. The Coala Care Portal can be easily accessed from any online computer or tablet. Integrate it with your EMR. The Coala does not require a special phone case or access to your smartphone's microphone. You can keep your headphones and hearing aids on and with Bluetooth connectivity your data is securely transmitted with less risk of electrical and mechanical interferences. Coala App is available for both iOS and Android.

Connected, integrated and intelligent

The unique, multi-patented technology is based on more than 10 years of R&D. The Coala consists of a unique high-performance sensor that records and digitizes the sounds of your heart, and with three smart electrodes that record and analyze your heart impulses by ECG. The digital platform with 1000 Hz, 24-bit ECG-technology delivers excellent high-quality ECG and analysis.

World-class clinical accuracy with P-wave and RR based analysis

The analytic, smart algorithms used in the Coala system are based on extensive research and long experience with analysis of arrhythmias and ECG signals. The algorithms are based on research presented in 40+ scientific journal papers and have been used in hundreds of thousands of ECGs. All developed in collaboration with researchers at the Karolinska Hospital and Lund Universities in Sweden.

Check out one of the published performance assessments here and the latest abstract here showing a Positive Predictive Value of 87%. Research has also been published in Circulation. For more info on the analyzing categories and specifications, see here

Minimized risk of artifacts and secure Bluetooth transmission

The Coala does not require a special phone case or access to your smartphone's microphone. You can keep your headphones and hearing aids on and with Bluetooth connectivity your data is securely transmitted with less risk of electrical and mechanical interferences. Coala App is available for both iOS and Android. Smart murmur detection The Coala Care portal has a unique digital Phonocardiogram (PCG) with smart algorithms to correlate the heart sound recording with ECG. The tool provides the caregiver with interpretation support to help detect signs of murmurs and other noise disturbances in the heart.

Predict and prevent with AI

Coala's smart algorithms, coupled with Artificial Intelligence and neural networks offers the ability to predict and ultimately prevent heart disease. A medical revolution, and simply nothing like it.

Coala Pro for Rx and patient engaged cardiac assessments

The Coala Pro (blue in color) is developed and offered to professional users to enable efficient multi-patient, high performance arrhythmia assessments as well as diagnosing and managing patients with AF in daily life. Ideal to track ECG recordings and interpretations between patient visits. Clinical yield and sensitivity at its best - simply digital telemedicine 2.0.

Used by leading Swedish healthcare providers

Hundreds of clinics are connected to the Coala Care system. The Coala Pro is used at leading University Hospitals, cardiology clinics and by primary care physicians to enable smart, patient engaged cardiac assessments. Designed to enable more cost-effective assessments, improved profitability and reduced need of specialist referrals. Interested Contact us here

When user engagement is important

The Coala Heart Monitor is used by thousands of Swedish consumers in their everyday life to help detect early signs of heart disease, alleviate worries and offload healthcare. Hundreds of clinicians and healthcare providers are connected to the Coala Care platform. User satisfaction is >90%.

Follow trends in the app, and include other variables such as blood pressure

The Coala App enables you to trend your data and include other clinical variables as blood pressure and weight. The Coala iOS app is also compatible with the Apple Health app to integrate heart beat data.

A smart digital service available for everyone, anywhere*

The consumer version is offered with different service plans. The Premium plan offers unlimited recordings and analysis, long term secure storage of data in the cloud, and direct connection to HeartCareLine™ (Hjärtupplysningen™) a health care provider (currently only available in Sweden).* The Coala is currently only offered in Sweden, but can easily be adapted for other regions and licensed as a system.

Simply the solution for your everyday life

Developed to enable preventive and early detection of heart disease by smart, validated algorithms for instant analysis of the heart. Helps to alleviate worries and powered by an eco-system that can be connected to any caregiver. The Coala is designed to help improve healthcare productivity and profitability - for more info, contact us here

Enabling groundbreaking clinical studies

The Coala is ideal for smart, digital studies. The RedHeart Study is one example - the world's largest clinical study to date on the female heart using digital health tools to assess palpitations and quality of life, run by Karolinska Institutet.

Award winning

Coala Life has been awarded with over 15 industry recognitions and honors for its innovations. If you also want to be part of the success story, partner or offer your patients the Coala as well - simply contact us here

A few of our awards

About us


Coala Life is a Swedish digital health venture on a mission to digitally transform the field of cardiac diagnostics - to help win the battle against the world’s leading cause of death. It’s about predicting and preventing cardiac disease, powered by smart algorithms and the individual.

The company has developed and launched a multi-prize-winning portfolio of cardiac monitoring solutions based on the Coala Heart Monitor, a cloud-based product and service for real-time analysis of the heart. The Coala Heart Monitor is unique in detecting Atrial Fibrillation based on both P-wave detection and RR variability, as well as 9 other arrhythmia's and the ability to help detect murmurs instantly.

Solutions are sold direct to individuals as well as to healthcare professionals to enable more efficient and digital cardiac assessments. It’s about digitizing the heart by the power and engagement of the individual and using smart algorithms to help predict and prevent heart disease. Sales are up and running in Sweden with broad IP in place protecting a portfolio of CE-approved Class IIa and FDA 510(k) cleared medical devices.

The core team originate from St Jude Medical and the company has an Apple Manufacturing License and tight collaborations with industry leaders as Bayer and Microsoft. Approximately 20 million USD raised to date and an impressive portfolio of international awards support the company.

We make it possible for everyone to monitor and analyze their heart. Anytime, anywhere.

The Coala Team

The Management
Dan Pitulia CEO och founding co-investor, Johanna Tulkki COO, Christian Pitulia CCO, Ann Hammarstrand CFO, Fredrik Bohman Quality & Regulatory Manager and Magnus Samuelsson CTO och co-founder.

The Board
Liselott Kilaas (chair), Sören Olofsson, Johanna Öberg, Ebba Fåhraeus, Anders Rodebjer and Jan Flood.


Tord Juhlin, MD, PhD, Senior consultant and Cardiologist, Skåne University Hospital. Tord is also the Chairman of the Swedish Cardiology Societies Heart Rhythm Group (HRG).

Hans-Jörgen Nilsson, MD, PhD, Workstream Lead Cardiology, Senior consultant and Cardiologist, Skåne University Hospital. Hans-Jörgen is currently active in the cardiology implementation of new region wide EMR system in Region Skåne.

Claes Held, MD, PhD, Senior consultant and associate Professor in Cardiology, Akademiska sjukhuset Uppsala (The Uppsala University Hospital). Claes is also a researcher active at Uppsala Clinical Research Center (UCR)

Ulf Tossman, PhD Neuropharmacology, CEO Orphelion AB, Co-founder of Coala Life AB. Ulf is also chairman/board member of several Swedish Life-science companies.


The Coala investors include some of Swedens most prominent doctors, professors, entrepreneurs, life science experts, business angels, institutional investors, family offices, the management team and lots of ordinary people sharing our mission and vision. Thank you.


Lots of fantastic cardiologists, GP's, nurses, professors, researchers, ambassadors within healthcare, experts on algorithms and signal processing, industrial designers, hw- and sw-developers, our manufacturing partners, everyone within Bayer, LloydsPharmacy, Medhelp, Microsoft, 1,6 miljonerklubben, other sales partners, super marketeers, lots of other experts in a number of fields, and most important of all - our customers. Thanks to you all - it's a team effort needed to help win the battle against the world's leading cause of death.


2019 Q4
  • First patients diagnosed and treated for Atrial Fibrillation in the US thanks to Coala
  • Coala's US advisory board assembled with leading industry professionals
2019 Q3
  • Coala Life is listed by the Wired as one of the 100 hottest start-ups in Europe.
  • Clinical performance results are presented on the Digital Health stage at the world's largest cardiology meeting - European Society of Cardiology (ESC) - including results from the Red Heart Study.
  • Coala Life expands into the US market with office in Irvine, CA, and sales team spread across USA.
  • Coala partners with Luscii and enters the Dutch market
2019 Q2
  • Coala Life Inc is established on the US market and first team on board.
  • Coala enters the German market in partnership with Arteriomed GmbH
  • Microsofts CEO Satya Nadella presents Coala Life as part of keynote presentation.
  • Coala Life elected by as the leading MedTech startup in Sweden.
  • Coala Life elected by Norrsken as one of the #theimpact100 companies, with goal and passion to solve global challenges.
  • Coala Life secures USD 10 million for expansion into the US market, read pressrelease here.
  • New research presented confirming the leading clinical accuracy of the Coala Heart Monitor, see here.
  • First results presented from The RedHeart Study – confirming that Coala Heart Monitor helps to alleviate worries and increase quality of life for women.
  • Launch of Hjärtflimmerkollen – a new medical service for digital screening for AF – open for everyone
2019 Q1
  • Coala Life signs commercialisation agreement with Apotek Hjärtat, the largest Pharmacy retailer in Sweden
  • Coala Heart Monitor is cleared by the FDA, read pressrelease here.
  • Coala Life is recognized as one of 100 top Global leaders in Digital Health by The Journal of mHealth
2018 Q4
  • Clinical advisory board formed consisting of cardiologists Tord Juhlin, Hans-Jörgen Nilsson and Claes Held. All industry leaders in their field and inspirational advisors.
  • Coala introduces new, unique algorithms with advanced P-wave detection and compatibility with Apple Health Records.
  • Performance assessment study presented at American Heart Association 2018, and published in Circulation.
  • Coala Life elected by research firm PUBLIC as one of the leaders of the digital transformation of public healthcare.
  • New clinical performance data of Coala presented at the annual fall meeting of the Swedish Clinical Physiologists.
2018 Q3
  • Launch of Coala Pro X - digital, cardiac assessments as-a-service.
  • Coala presents at the Health 2.0 conference in Santa Clara, US.
  • Coala attends and presents at the Digital Health Pavilion of ESC 2018, the largest cardiovascular meeting in the world.
  • Agreement signed with Capio, one of Europe’s largest healthcare companies, to offer Coala Heart Monitor Pro in Primary Care to insurance patients.
  • Coala named "Cool Vendor 2018" by Gartner.
  • Coala is featured on TV4 Nyhetsmorgon (leading morning show on Swedish television).
  • Coala Life and Microsoft run joint seminars on AI and future of digital health at Almedalen week, Sweden
2018 Q2
  • Coala Life is recognized by Red Herring as one of Europe's Top-100 start-ups.
  • Coala Life wins the People's Choice Award of the prestigious 2018 Grand Award of Design.
  • Publishing of clinical performance data at the 2018 Spring Cardiovascular Spring meeting in Stockholm.
  • Coala wins the EBAN (The European Trade Association for Business Angels, Seed Funds and Early Stage Market Players) eHealth Investment Seminar Pitch in Gothenburg, Sweden.
  • Results from joint-project with Praktikertjänst (the largest private healthcare provider in Sweden) is presented proving a reduction in specialist referrals with almost 40%, with reduced costs and satisfied users as results.
  • Coala strengthens the Board and organization with a fantastic quartet of industry leaders.
  • New apps released with trend monitoring, link to Apple Health and ability to link in external data such as blood pressure.
  • Coala wins the Makerstown 2018 Jury Award in Brusseles, among leading innovation and start-up companies from across Europe.
  • Coala celebrates 100,000 conducted ECG-measurements in Sweden using the Coala Heart Monitor.
  • Coala Life partners with Karolinska Institutet to run the RedHeart Study.
  • Coala Life finalist and part of the Serendipity Challenge 2018 event, among 50 of Swedens most innovative future leaders.
  • Coala Life raises additional SEK 16 million (approx. USD 2 million) to accelerate growth.
2018 Q1
  • The University Hospital in Lund starts using the Coala Pro for smart and Digital cardiac assessments.
  • Coala Life wins the Startup World Cup finals in Sweden and heading for the global grand finale in Silicon Valley.
  • Coala Life is awarded the Digital Hospital Award 2018. Continued market roll-out in Sweden and first steps taken to go international.
2017 Q4
  • Coala Life signs deal with global life science company Bayer.
  • Coala Life raises additional growth capital and extends the Board.
  • Coala receives a major grant from the Swedish Governmental agency for Innovation Systems (Vinnova) to further develop Artificial Intelligence to enable early prediction of heart disease.
  • Coala Life wins the Sweden Demo Day 2017 Pitch with over 100 finalists.
  • Coala Life launches Coala Labs in Sweden for smart, digital cardiac clinical investigations.
  • New set of algorithms are released for murmur detection by smart correlation of ECG and heart sounds.
2017 Q3
  • Coala Life is awarded the prestigious Rising Star Award 2017 at the Swedish American Life Science Summit.
  • Coala is used in unique new clinical study on stroke patients.
2017 Q2
  • Launch of the Coala Pro, a unique digital solution for caregivers and professional users to enable efficient, high performance yet simple arrhythmia assessments as well as diagnosing and managing patients with AFIB.
  • Coala Life wins the prestigious eHealthAward 2017, handed over by the Swedish Minister of Health.
2017 Q1
  • Coala Life is honored as a finalist in the Swedish Mobile Awards 2017
  • Coala Life is a proud winner and part of "Sweden’s 33 hottest tech companies list 2017".
  • The Coala is launched in Sweden and sold online and in retail by LloydsPharmacy in Sweden. Consumers buy the Coala and subscribe for the service, and many Swedish health care providers access the data in the Coala Care Portal. Hjärtupplysningen (HeartCareLine) is established in Sweden as the first integrated care provider offering cardiac consultation based on the Coala for Premium subscribers.
2016 Coala Life collaborates with industry leaders such as Microsoft, Ericsson, Sigma and Stockholm Heart Center in preparation for the upcoming market launch. Coala is CE-approved and Coala Life is ISO 13485 certified. LloydsPharmacy signs agreement to retail the Coala in Sweden. 2015 The fourth generation technology platform and analysis algorithms are successfully verified. Coala is developed into a unique, medical technology system that allows users to monitor their heart any time, any place and very easily. An innovative and true e-health service in collaboration with caregivers. Coala Atlas is created. Coala Life is awarded additional patents. Major Swedish studies confirm that preventative ECG screening leads to both earlier and more frequent detection of atrial fibrillation. 2014 Coala Life AB is founded as a commercialization entity of the previous Cometech and R&D projects. 2004-13 Coala research is initiated by Swedish entrepreneurs and physicians with the goal of developing wireless systems for digital monitoring and diagnosing of the heart. In 2007, the first generation Coala technology platform is developed and the first patent is approved. In 2013, Coala reaches a technological breakthrough. The fourth generation's new digital technology platform provides a completely new way of screening patients by digitizing heart sounds, simultaneously taking an ECG on the chest and analysing the data in the cloud. 2001 The European Society for Cardiology (ESC) and the American Heart Association (AHA) publish the first, joint, international guidelines that recommend ECG monitoring to detect and diagnose atrial fibrillation. 1991 A key publication included in the comprehensive Framingham study, confirms that atrial fibrillation increases the risk of stroke considerably. 1900 The Dutch physiologist Willem Einthoven develops the first real equipment for recording ECG signals. A solution that weighed approximately 270 kg and required five people to conduct the examination. 1821 The analogue stethoscope is invented by the French physician Rene Laennec. Today, there are over 25 million units on the market.
Dan Pitulia
CEO and founding co-investor
Tel: +44 7849 257532
Titti Lundgren
CMO and co-founder
Lovisa Fasth
E-commerce and Digital Manager